AtriCure, Inc. (ATRC)
27.12
-0.86
(-3.07%)
USD |
NASDAQ |
Jun 17, 16:00
27.12
0.00 (0.00%)
After-Hours: 20:00
AtriCure SG&A Expense (Quarterly) : 84.55M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 84.55M |
| December 31, 2025 | 78.34M |
| September 30, 2025 | 78.23M |
| June 30, 2025 | 78.39M |
| March 31, 2025 | 76.05M |
| December 31, 2024 | 72.18M |
| September 30, 2024 | 73.24M |
| June 30, 2024 | 73.60M |
| March 31, 2024 | 72.34M |
| December 31, 2023 | 67.69M |
| September 30, 2023 | 61.60M |
| June 30, 2023 | 63.78M |
| March 31, 2023 | 60.06M |
| December 31, 2022 | 55.50M |
| September 30, 2022 | 57.27M |
| June 30, 2022 | 62.39M |
| March 31, 2022 | 56.12M |
| December 31, 2021 | 53.71M |
| September 30, 2021 | 49.87M |
| June 30, 2021 | 56.96M |
| March 31, 2021 | 49.21M |
| December 31, 2020 | 49.07M |
| September 30, 2020 | 33.75M |
| June 30, 2020 | 24.90M |
| March 31, 2020 | 42.75M |
| Date | Value |
|---|---|
| December 31, 2019 | 47.00M |
| September 30, 2019 | 40.28M |
| June 30, 2019 | 37.93M |
| March 31, 2019 | 37.02M |
| December 31, 2018 | 32.74M |
| September 30, 2018 | 33.44M |
| June 30, 2018 | 28.47M |
| March 31, 2018 | 34.88M |
| December 31, 2017 | 27.10M |
| September 30, 2017 | 29.80M |
| June 30, 2017 | 30.00M |
| March 31, 2017 | 30.10M |
| December 31, 2016 | 26.73M |
| September 30, 2016 | 25.49M |
| June 30, 2016 | 27.43M |
| March 31, 2016 | 26.77M |
| December 31, 2015 | 28.41M |
| September 30, 2015 | 22.10M |
| June 30, 2015 | 22.07M |
| March 31, 2015 | 21.27M |
| December 31, 2014 | 20.20M |
| September 30, 2014 | 14.66M |
| June 30, 2014 | 17.06M |
| March 31, 2014 | 21.58M |
| December 31, 2013 | 16.86M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Abbott Laboratories | 3.74B |
| Boston Scientific Corp. | 1.781B |
| AngioDynamics, Inc. | 38.16M |
| Alphatec Holdings, Inc. | 137.06M |
| Baxter International, Inc. | 728.00M |